ANI PHARMACEUTICALS INC 10-K filing
Filed 2026-02-27 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001023024-26-000014
- Form type
- 10-K
- CIK
- 0001023024
- Primary document
- https://www.sec.gov/Archives/edgar/data/1023024/000102302426000014/anip-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANI PHARMACEUTICALS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $883.4M | - | - |
| Operating Income | $111.1M | - | - |
| Net Income | $78.3M | - | - |
| Eps Basic | 3.5 | - | - |
| Eps Diluted | 3.32 | - | - |
| Cash And Equivalents | $285.6M | - | - |
| Total Assets | $1.4B | - | - |
| Total Liabilities | $899.7M | - | - |
| Shareholders Equity | $540.7M | - | - |
| Operating Cash Flow | $185.2M | - | - |
| Capital Expenditures | $13.8M | - | - |